Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06960720 · ClinicalTrials.gov registry record · NA

Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management

A NA study of Breast Cancer and Fatigue, sponsored by West Virginia University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06960720: Recruiting NA study of Breast Cancer and Fatigue, sponsored by West Virginia University.

NCT06960720 is a NA study of Breast Cancer and Fatigue that is actively recruiting participants, run by West Virginia University. The registered enrollment target is 60 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06960720, a NA study of Breast Cancer and Fatigue, is actively recruiting participants, sponsored by West Virginia University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The long-term goal of this project is to improve the implementation of tailored resistance exercise interventions for Appalachian breast cancer survivors. To achieve this goal, the primary objective is to enhance the understanding of how biological, psychological, and social factors interact to influence readiness for behavior change around resistance exercise in this unique population. The primary aim is to evaluate the feasibility of delivering the Strength After Breast Cancer (SABC) program, focusing on how socioeconomic status (SES) and allostatic load (AL) scores influence adherence and dropout rates. The Investigators will also further examine how self-efficacy, outcome expectations, and social support influence behavior change related to resistance exercise participation. The central hypothesis is that participants with lower SES will report geographic or financial constraints, receive reduced support from family or peers, have low confidence in their ability to exercise, and demonstrate lower adherence rates. Participants will: * Use a clear, step-by-step guide for safe, progressive strength training using a resistance exercise program tailored specifically for breast cancer survivors for a duration of 3 months * Keep an exercise log and complete questionnaires

Primary Outcome

Percentage of participants in the lower SES group who drop out of the program

Conditions Studied

Interventions

  • OTHER Resistance Exercises

Study Locations (1)

West Virginia

  • West Virginia University - Morgantown

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-10-13
Est. Completion 2027-08
Phase NA
West Virginia University

122 total trials

What NCT06960720 shows while recruiting

NCT06960720 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Resistance Exercises is the first listed.

NCT06960720 reports a single indexed study location in West Virginia.

Frequently Asked Questions

What is clinical trial NCT06960720 about?

NCT06960720 is a clinical study titled "Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management". The long-term goal of this project is to improve the implementation of tailored resistance exercise interventions for Appalachian breast cancer survivors. To achieve this goal, the primary objective is to enhance the understanding of how biological, psychological, and social factors interact to infl...

What is the current status of trial NCT06960720?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-10-13. Estimated completion is 2027-08.

What conditions does trial NCT06960720 study?

This clinical trial studies the following conditions: Breast Cancer, Fatigue.

What interventions are being tested in trial NCT06960720?

The interventions under investigation include: Resistance Exercises (OTHER).

Who is sponsoring clinical trial NCT06960720?

This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06960720 being conducted?

This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06960720's enrollment target sits among peer trials

60 736th of 1224 higher than 468 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06960720, the US trial registry maintained by the National Library of Medicine. NCT06960720 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.